Upper respiratory swabs, such as the nasopharyngeal (NP) swab, have so far been major specimen sources used for the SARS-COV-2 molecular test. However, due to the discomfort and invasiveness of NP collection, and the expense of personal protective equipment, alternative sampling sources such as saliva are desired. The purpose of this proposed study is: 1) to examine whether saliva can be used as an specimen for the SARS-COV-2 molecular test; 2) to test if gingival crevicular fluids is a reliable specimen for the SARS-COV-2 antibodies.
Other: Saliva collection
Use Spectrum Solutions SDNA1000 or Orasure collection kit or dry tube to collect 1-3 ml of saliva
Inclusion Criteria:
- Persons referred for COVID-19 testing including those with COVID-19 symptoms and/or a
suspected SARS-COV-2 infection or undergoing surveillance testing and
- Is able to give informed consent
- Is able to understand oral or written instructions, and
- Is able to mentally and physically perform self-collection of saliva using the
provided collection device.
Exclusion Criteria:
- - Adults unable to consent
- Individuals who are not yet adults (infants, children, teenagers)
- Employees of Paradigm lab and the assisted living facilities involved in the study
- Members of other vulnerable populations
Paradigm Laboratories
Tucson, Arizona, United States
Wenli Zhou, PhD, Principal Investigator
Paradigm Laboratories